Inventor · disambiguated record
Dimitrios Iliopoulos
Also filed as: ILIOPOULOS DIMITRIOS
7 granted patents·10 pending applications·1 citations·filing 2010–2024
71Inventor score
Files withATHOS THERAPEUTICS INC7UNIV CALIFORNIA4CHILDRENS MEDICAL CENTER2ATTICA SCIENCES LTD1PROTEAS BIOANALYTICS INC1
Top patents by PatentIndex Score
17 records- 0166US9938354B2Lin28-mediated control of let-7 biogenesisCHILDRENS MEDICAL CENTER·Filed 2014·Granted Apr 10, 2018·1 cites·8 claims
- 0261US10865252B2Lin28-mediated control of let-7 biogenesisCHILDRENS MEDICAL CENTER·Filed 2018·Granted Dec 15, 2020·0 cites·13 claims
- 0353US12414960B2Analogues of oleuropein and oleacein and uses thereofATTICA SCIENCES LTD·Filed 2021·Granted Sep 16, 2025·0 cites·32 claims
- 0453US11952362B2Compositions and methods for treating epigenetic diseaseUNIV CALIFORNIA·Filed 2019·Granted Apr 9, 2024·0 cites·11 claims
- 0553US2025066353A1Vanin-1 inhibitorsATHOS THERAPEUTICS INC·Filed 2024·Application pending·0 cites
- 0652US2023159498A1Small molecules for the treatment of autoimmune diseases and cancerATHOS THERAPEUTICS INC·Filed 2022·Application pending·0 cites
- 0750US11485728B2Small molecules for the treatment of autoimmune diseases and cancerATHOS THERAPEUTICS INC·Filed 2021·Granted Nov 1, 2022·0 cites·12 claims
- 0850US2024103007A1Mass spectrometry sample processing methods, chromatography devices, and data analysis techniques for biomarker analysisPROTEAS BIOANALYTICS INC·Filed 2021·Application pending·0 cites
- 0946US2016102361A1Neurotensin-induced tumor formation is regulated by micro rna 133a-aftiphilin-dependent receptor recyclingUNIV CALIFORNIA·Filed 2014·Application pending·0 cites
- 1042US10233463B2Neurotensin-induced tumor formation is regulated by micro RNA 133A-aftiphilin-dependent receptor recyclingUNIV CALIFORNIA·Filed 2016·Granted Mar 19, 2019·0 cites·13 claims
- 1141US2025042850A1Pharmaceutical compounds and methods of making and using the sameATHOS THERAPEUTICS INC·Filed 2022·Application pending·0 cites
- 1241US2024199597A1Small molecules for the treatment of kinase-related diseasesATHOS THERAPEUTICS INC·Filed 2022·Application pending·0 cites
- 1340US2025188062A1Triazine compounds and methods of making and using the sameATHOS THERAPEUTICS INC·Filed 2022·Application pending·0 cites
- 1438US2025244312A1Ex vivo colonic biopsy platform to evaluate multi-omic signatures for screening candidate therapeuticsATHOS THERAPEUTICS INC·Filed 2021·Application pending·0 cites
- 1531US2017333468A1Mir-214 as a diagnostic and prognostic biomarker specific for ulcerative colitis and a mir-214 inhibitor for treatment of sameUNIV CALIFORNIA·Filed 2015·Application pending·0 cites
- 1625US2012220664A1Use of metformin in cancer treatment and preventionSTRUHL KEVIN·Filed 2010·Application pending·0 cites
- 1722US8617818B2Compositions and methods for diagnosis and prognosis of cancer and progression, and for screening anti-cancer agentsTSICHLIS PHILIP N·Filed 2011·Granted Dec 31, 2013·0 cites·13 claims
Join the waitlist — get patent alerts
Get an alert when Dimitrios Iliopoulos files or is granted a new patent.
We store only your email — no account needed. See our privacy policy.
Identity basis: PatentsView inventor disambiguation (2025Q4-odp release). How scoring works →